These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8320581)
21. A laboratory procedure for evaluation of pharmacotherapy for cocaine dependence. Kranzler H; Bauer L NIDA Res Monogr; 1989; 95():324-5. PubMed ID: 2640979 [No Abstract] [Full Text] [Related]
23. 'Crack'. Early report on a new drug epidemic. Washton AM; Gold MS; Pottash AC Postgrad Med; 1986 Oct; 80(5):52-4, 57-8. PubMed ID: 3763534 [No Abstract] [Full Text] [Related]
24. Use of a cue exposure paradigm for the evaluation of a potential pharmacotherapeutic agents for cocaine dependence. Kranzler HR; Bauer LO Addict Behav; 1993; 18(6):599-60. PubMed ID: 8178699 [No Abstract] [Full Text] [Related]
25. Serum prolactin levels during extended cocaine abstinence. Swartz CM; Breen K; Leone F Am J Psychiatry; 1990 Jun; 147(6):777-9. PubMed ID: 2343924 [TBL] [Abstract][Full Text] [Related]
26. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Tennant FS; Sagherian AA Arch Intern Med; 1987 Jan; 147(1):109-12. PubMed ID: 3541819 [TBL] [Abstract][Full Text] [Related]
27. Bromocriptine abuse. Ross RG; Ward NG Biol Psychiatry; 1992 Feb; 31(4):404-6. PubMed ID: 1558903 [No Abstract] [Full Text] [Related]
28. The use of bromocriptine for the treatment of attention deficit disorder in two chemically dependent patients. Cavanagh R; Clifford JS; Gregory WL J Psychoactive Drugs; 1989; 21(2):217-20. PubMed ID: 2668485 [TBL] [Abstract][Full Text] [Related]
30. Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels. Gorelick DA; Wilkins JN Drug Alcohol Depend; 2006 Feb; 81(2):189-95. PubMed ID: 16051446 [TBL] [Abstract][Full Text] [Related]
31. Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats. Knuepfer MM; Gan Q J Pharmacol Exp Ther; 1997 Nov; 283(2):592-603. PubMed ID: 9353374 [TBL] [Abstract][Full Text] [Related]
32. Central stimulant abuse: neurochemistry and pharmacotherapy. Dackis CA; Gold MS; Pottash AL Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014 [TBL] [Abstract][Full Text] [Related]
33. Effects of bromocriptine on subjective and autonomic responses to cocaine-associated stimuli. Kranzler HR; Bauer LO NIDA Res Monogr; 1990; 105():505-6. PubMed ID: 1876100 [No Abstract] [Full Text] [Related]
34. Clinical trials of pharmacologic treatments in pregnant women--methodologic considerations. Schottenfeld RS NIDA Res Monogr; 1995; 149():201-23. PubMed ID: 8775841 [No Abstract] [Full Text] [Related]
35. [Unexpected positive effect of bromocriptine on obesity and the use of psychopharmaceuticals]. Larsson LO; Blom HL Lakartidningen; 1985 Dec; 82(50):4425, 4427. PubMed ID: 4079615 [No Abstract] [Full Text] [Related]
36. Amantadine in the treatment of cocaine withdrawal. Thompson DF Ann Pharmacother; 1992; 26(7-8):933-4. PubMed ID: 1504406 [No Abstract] [Full Text] [Related]
37. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis. Jones RT NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801 [No Abstract] [Full Text] [Related]
38. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Markou A; Koob GF Neuropsychopharmacology; 1992 Nov; 7(3):213-24. PubMed ID: 1388645 [TBL] [Abstract][Full Text] [Related]